SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs remains a focal point for investors as they monitor high steel pricing against ongoing debt concerns and the high-stakes potential of a strategic partnership with POSCO. Community sentiment is deeply divided, with many traders debating whether the stock is an undervalued infrastructure play linked to AI-driven demand or a high-risk asset hampered by corporate leadership.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors remain divided over the company's valuation, recent stock-based compensation, and the ongoing legal challenge regarding CMS reimbursement policies. While the community actively debates whether the stock is significantly undervalued given Ibsrela's revenue growth or if management's spending is stalling momentum, many investors are focused on upcoming clinical trial data and potential legislative action as key catalysts.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is experiencing a period of heightened volume and volatility as investors react to a significant new partnership with Jazz Pharmaceuticals and look ahead to critical clinical readouts later this year. The stock is currently a major focus of community debate, with bulls highlighting the long-term potential of the company's AI-driven drug discovery platform, while bears remain focused on historical underperformance and the risks inherent in upcoming trial data.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as the community debates a potential rebound fueled by the return of NBCUniversal channels and excitement surrounding the FIFA World Cup. While bulls point to these catalysts and institutional price targets as signs of a turnaround, bears remain focused on historical share price declines, insider selling, and ongoing skepticism regarding the company's long-term profitability.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is trending as investors aggressively rotate into storage and memory stocks amid persistent AI infrastructure demand, with the community actively debating whether the rally represents a fundamental structural repricing or a speculative bubble prone to a sharp correction. Bullish sentiment is fueled by heavy institutional accumulation and supply chain bottlenecks, while skeptics warn of extreme valuations and potential exhaustion in the memory cycle.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is trending following its recent integration with MetaMask Mobile and the launch of a new savings app designed to compete with traditional banking, fueling community optimism around its long-term growth. Investors are actively discussing the protocol's protocol revenue, potential for institutional RWA adoption, and its comparative valuation against DeFi rivals.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending as investors weigh potential regulatory outcomes for RGX-121 following recent clinical hold and BLA resubmission updates, with the community closely tracking whether the FDA will issue a decision or a further delay on the upcoming PDUFA date. Discussions are heavily focused on the company's cash position, the impact of rare disease regulatory scrutiny, and the long-term potential of the pipeline including RGX-202 and the partnership with AbbVie.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors focus on its inclusion in the Russell 2000 and the potential for a share price surge driven by passive inflows and high short interest. Community discussion remains heavily polarized between bulls anticipating a strategic buyout based on the AXPAXLI clinical data and bears betting against the company's reliance on a single pivotal trial for regulatory approval.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is facing intense scrutiny as investors debate the impact of ongoing SEC inquiries and high-stakes litigation, while the community remains sharply divided over the sustainability of its business model. Conversations are heavily polarized between those betting on a potential turnaround or short squeeze and vocal critics who argue that the stock's valuation ignores mounting debt and aggressive insider selling.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing significant investor interest driven by its strategic pivot toward pharmaceutical infrastructure and potential government-backed onshoring opportunities. The community is actively discussing the stock's potential for a major rerating as they monitor ongoing regulatory developments, supply chain mandates, and managements execution of its long-term business transformation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the Vanguard Information Technology Index Fund ETF Shares (VGT)?

US-Iran Deal Hopes: ETFs to Buy & Avoid

US-Iran deal hopes may ease oil prices, curb inflation and lift risk appetite. Here are some ETFs that could win, and those that may lag.

Here's How Much $1000 Invested In Vanguard Information Tech ETF 20 Years Ago Would Be Worth Today

Vanguard Information Tech ETF (NYSE:VGT) has outperformed the market over the past 20 years by 7.07% on an annualized basis producing an average annual return of 16.25%. Currently, Vanguard Information Tech ETF has aread more...

Jim Paulsen Sounds Alarm On US Stocks, Sees Correction Signs ‘Ripening’ – ‘My Enthusiasm For Stocks Is Waning…’

Equity

Veteran economist Jim Paulsen said he is growing increasingly cautious on U.S. stocks but has played down the chances of a recession in the near term.

Bitcoin’s Rout Reignites The 'Digital Gold' Debate – Here’s What Analysts Are Saying

Bitcoin crashed to near four-month lows on Thursday, while spot gold prices rose nearly 1%.

AI Stock Jumps 3% After-Hours — Founder Siebel Returns As CEO With $69M Cash Injection

The stock climbed despite another quarter of revenue declines and operating losses year over year.


Tech ETFs to Buy as NVIDIA Sets Foot Into PC Market via New AI Chip

Tech ETFs with heavy exposure to NVDA gain attention, as the company enters the PC market with its RTX Spark AI superchip.

APPS Stock Soars 53%, On Track For Best Single-Day Gains In 11 Months — Why Did BofA Turn Bullish On Digital Turbine?

Digital Turbine reported earnings per share of $0.16 in Q4 on revenue of $143 million, while Wall Street expected an EPS of $0.09 on revenue of $133 million.

Chamath Palihapitiya Rips Into Cloudflare CEO's Layoff Memo: 'I Think You Did A Horrible Job'

Palihapitiya added that Matthew Prince’s memo has reduced employees to a label, while saying that he couldn’t have written a worse one.

OUST Stock Hits 52-Week High Today — What Is The Counter-Drone Partnership With ARGUS About?

ARGUS plans to use Ouster's sensors to improve non-kinetic counter-drone operations, particularly in environments where traditional interception methods are impractical.

Vanguard World Fund - Vanguard Information Technology ETF

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$113.86
Prev Close	$115.47
Open	$113.58
Dividend Yield	N/A
50-Day Moving Average	$112.26
Beta	N/A
Avg. Volume	4.64M
PE Ratio	N/A

52-Week High	$126.00
52-Week Low	$81.47
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

VGTVanguard Information Technology ETF

Latest VGT News